Astem-101 Allogenic human umbilical cord derived mesenchymal stem cell (hUC-MSCs)(Shanghai Angsheng Biomedical)

Astem-101人脐带间充质干细胞（hUC-MSCs）（上海昂昇生物）

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAstem-101 Allogenic human umbilical cord derived mesenchymal stem cell (hUC-MSCs)(Shanghai Angsheng Biomedical)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2Erectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Angsheng Biomedical Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Angsheng Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Erectile Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A